A type 2, the fastest growing epidemic of the century, now sits at the epicenter of a global health crisis because of its sheer size, its unstoppable rise, and its ability to invisibly drive other, more visible health conditions. Current global estimates suggest 589 million adults (20-79 years of age, about one in nine) are living with the disease today, which is expected to increase to 853 million by 2050 (one in eight). Growth is not just around the corner;
